Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for Chemotherapy Induced Neuropathic Pain
NCT00872144Phase 3Completed
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in neuropathic pain comparing Sativex with Placebo (2 arms). Primary endpoints: Change in the Numerical Rating Scale for Pain Intensity at 3 weeks and Proportion of Participants with >=30% Reduction in NRS-PI at 3 weeks. Started Jun 2010; status: completed.
02
Drugs
cannabidiol
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT00872144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00872144.